Physician profile
Michael Gibson
NPI 1356737464
$7,895.05
in general payments reported to CMS, 2019-2025
11 companies · $54.73 in 2025
The $54.73 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $723 · 2020: $772 · 2021: $1,836 · 2022: $1,408 · 2023: $2,519 · 2024: $583 · 2025: $54.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,934 · Travel and Lodging: $1,206 · Entertainment: $15.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,934.46 |
| Travel and Lodging | $1,206.01 |
| Entertainment | $15.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,155.09 | 2019-2024 | Proclaim, Eterna |
| Spr Therapeutics, INC | $2,034.53 | 2022-2024 | Sprint Pns System |
| Nalu Medical, INC. | $914.36 | 2022 | |
| Foundation Fusion Solutions, LLC | $671.30 | 2021-2023 | |
| Boston Scientific Corporation | $459.23 | 2019-2020 | |
| Medtronic, INC. | $234.30 | 2021-2022 | |
| Medtronic USA, INC. | $233.08 | 2019-2020 | |
| Vertiflex, INC. | $98.92 | 2019 | |
| Viiv Healthcare Company | $54.73 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.10 | 2020 | |
| Relievant Medsystems, INC. | $19.41 | 2023 | Intracept |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Gibson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.